7
May
2024

Dow Development Laboratories

Exhibitor at CPHI North America 2024 stand 1357
About Us

Dow Development Laboratories (DDL) core expertise is in the development, manufacture, and testing of topical liquid and semi-solid drug products for clinical use. Products are filled, packaged and labeled in house and distributed to clinical sites. Always with the patient in mind, products are designed to be disease-compatible, cosmetically elegant and stable.  Our formulation, analytical, production, quality, and clinical labeling teams have decades of experience moving products quickly toward regulatory approval.  

  • US
  • 2024
    On CPHI since
  • 1
    Certificates
  • 25 - 49
    Employees
Company types
CMO/CDMO
Primary activities
Contract Research Organisation
Contact info
Event information
CPHI North America 2024
  • 07 May 2024 - 09 May 2024
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 1357